Image Enhanced Endoscopy Technology to Improve the Detection of Colorectal Dysplasia in Patients With Inflammatory Bowel Disease

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Dye- spray chromoendoscopy remains the recommended gold standard approach for IBD dysplasia surveillance colonoscopy however recently published European and American guidelines recommend either dye-spray or virtual chromoendoscopy can be used for surveillance. The newer Imaged Enhanced Endoscopy technologies TXI and LCI have not formally been evaluated in IBD surveillance in a randomised controlled trial setting. These modes can easily be applied during colonoscopy and if demonstrated to be effective may save time and eliminate the need for dye-spray chromoendoscopy in the future.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: t
View:

• Patients with inflammatory bowel disease aged 18 to 75 years, that meet Australian recommendations to undergo surveillance colonoscopy will be identified and invited participate in the study.

Locations
Other Locations
Australia
Royal Perth Hosptial
RECRUITING
Perth
Contact Information
Primary
Sherman Picardo, MBBS (hon), MSc
sherman.picardo@health.wa.gov.au
0892242244
Time Frame
Start Date: 2024-04-03
Estimated Completion Date: 2026-03-01
Participants
Target number of participants: 270
Treatments
Placebo_comparator: Dye Spray Chromoendoscopy
Patients undergoing surveillance with dye spray chromoendoscopy
Active_comparator: TXI
Patients undergoing surveillance with TXI (Texture and Colour Enhancement Imaging)
Active_comparator: LCI
Patients undergoing surveillance with LCI (Linked Colour Imaging )
Sponsors
Leads: Royal Perth Hospital

This content was sourced from clinicaltrials.gov